Ormalvi Tablet
Product Images NDC 70709-085

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ormalvi (NDC 70709-085). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cycle Pharmaceuticals Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (100counts)

Image Description (100counts)
Packaging label for ORMALVI 50 mg tablets, containing the active ingredient dichlorphenamide. The label indicates a package size of 100 tablets, manufactured by Zenara Pharma Pvt. Ltd., India, and labeled for Cycle Pharmaceuticals Ltd., UK. It includes storage instructions and a barcode with NDC 70709-085-10.*
FDA Label Image
FDA Label Image

Image Description (Structure)

Image Description (Structure)
Chemical structure of dichlorphenamide showing a benzene ring with two chlorine atoms, two sulfonamide groups, and amine groups attached to the ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.